Table 3.
Complications’ treatment and mortality
| References | Total sample size | Sample size pAE N (% of total) | Hepatic necrosis N (% of total pAE) | HN treatment N (% of total HN) | Deaths related to HN after treatment N (% of total HN) | ||||
|---|---|---|---|---|---|---|---|---|---|
| NOM | Resection | Debridement | NOM | Resection | Debridement | ||||
| Dabbs et al. [9] | 538 | 71 (13%) | 30 (42%) | 0 | 16 (53%) | 14 (47%) | – | 2 (7%) | 0 |
| Kong et al. [10] | – | 70 | 11 (16%) | 11 (100%) | 0 | 0 | 0 | – | – |
| Letoublon et al. [11] | 183 | 13 (7%) | 1 (8%) | 0 | 0 | 1 (100%) | \ | \ | 1 (100%) |
| Li et al. [12] | 268 | 22 (8%) | 0 | – | – | – | – | – | – |
| Misselbeck et al. [7] | 707 | 20 (3%) | 4 (20%) | 1 (25%) | 0 | 3 (75%) | 1 (25%) | – | 0 |
| Mohr et al. [15] | 866 | 11 (1%) | 3 (27%) | 0 | 1 (33%) | 2 (67%) | – | 1 (33%) | 0 |
| Monnin et al. | 84 | 10 (12%) | 1 (10%) | 0 | 0 | 1 | – | – | 1 (100%) |
| Saltzherr et al. | 116 | 23 (20%) | 3 (13%) | 3 | 0 | 0 | 0 | – | – |
| Sekine et al. | 72 | 14 (19%) | 1 (7%) | 0 | 1 | 0 | – | 0 | – |
| Wahl et al. [13] | 126 | 6 (4 successful, 3%) | 0 | – | – | – | – | – | – |
| Xu et al. [14] | 683 | 114 (106 successful, 16%) | 3 (3%) | 0 | 0 | 3 | – | – | 0 |
| TOT | 3643 | 364 (10%) | 57 (16%) | 15 (26%) | 18 (32%) | 24 (42%) | 1 (2%) | 3 (5%) | 2 (4%) |